Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 1st Qtr Business Results
August 29, 2005
- Caiapo Launched in Australia, New Zealand
August 29, 2005
- NHI Prices May Be Revised Once a Year if Generics Are Listed Twice a Year: Mr Mukaida
August 29, 2005
- Cabinet Approves \47.5 Tril. Ceiling for FY2006 Budget
August 29, 2005
- Measures Suggested for Drugs for Which Dissolution Tests Are Difficult: Quality Reevaluation
August 29, 2005
- Uncollected Medical Fees - Why Don't Patients Pay?
August 29, 2005
- REGULATORY NEWS IN BRIEF
August 29, 2005
- FDGscan May Dramatically Change Cancer Diagnosis in Japan
August 29, 2005
- Ono Announces Results of PII Study of Cereact for ALS
August 29, 2005
- FDGscan Also Provides Benefits to Existing PET Facilities
August 29, 2005
- R&D NEWS IN BRIEF
August 29, 2005
- AnGes MG, Avontec GmbH Sign Cross-licensing Agreement
August 29, 2005
- IMS Japan, ACNielsen Japan Launch OTC Market Analysis Tool
August 29, 2005
- Nippon Chemiphar Licenses NC-2300 to Velcura Therapeutics
August 29, 2005
- SELF-MEDICATION NEWS IN BRIEF
August 29, 2005
- Sales of Ethical Drugs Up 6% in April-June Period: IMS Japan
August 29, 2005
- JCQHC Analyzes 18 Surgical, 47 Drug-related Accidents
August 29, 2005
- Kainos to Strengthen Blood Transfusion Screening Business with Immucor
August 29, 2005
- Gov't-Managed Health Insurance Shows Surplus for 2nd Consecutive Year
August 29, 2005
- Toyobo Completes New Contract Production Facility in Otsu
August 29, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…